Weight-loss drug delayed
US health regulators have delayed their decision on whether to approve Sanofi-Aventis' highly anticipated weight loss drug, Acomplia.
Read the rest of this entry ... (87 words left)
Weight loss drugs blog provide information and news for different weight loss drugs.
2007/2/25
2007/2/21
Diet Drug Acomplia Seen Unlikely to Get FDA Approval for 'Metabolic Syndrome'
If you were hoping that diet drug rimonabant (Acomplia / Zimulti) would be approved for treatment of "metabolic syndrome" so your insurance company would be more likely to pay for your weight-loss efforts, the current thinking at the U.S. Food and Drug Administration does not appear very encouraging.
Read the rest of this entry ... (139 words left)
